CBTI-CS: A Novel Cognitive-Behavioral Treatment for Insomnia in Cancer Survivors
2 other identifiers
interventional
56
1 country
1
Brief Summary
This research study is evaluating the effectiveness of a 3-session behavioral intervention for insomnia in cancer survivors. This is a behavioral intervention study, and no medications are involved.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2015
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2015
CompletedFirst Submitted
Initial submission to the registry
April 26, 2016
CompletedFirst Posted
Study publicly available on registry
April 29, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 14, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
May 14, 2018
CompletedDecember 11, 2018
December 1, 2018
2.5 years
April 26, 2016
December 10, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The Insomnia Severity Index (ISI)
The ISI is a 7-item self-report questionnaire assessing severity, and impact of insomnia symptoms.
Change from Baseline to 4-weeks post-intervention
Secondary Outcomes (2)
Profile of Mood States - Short Form (POMS-SF)
Change from Baseline to 4 & 8 weeks post-intervention
The Insomnia Severity Index (ISI)
Change from Baseline to 8 weeks post-intervention
Study Arms (2)
Arm A (Sleep Hygiene & CBTI-CS)
EXPERIMENTALParticipants receive a single educational session describing principles of Sleep Hygiene for Cancer Survivors. Those who continue to have significant symptoms of insomnia then receive 3 groups CBTI-CS sessions
Arm B (Telehealth Pilot of CBTI-CS)
OTHERDescriptive data collected on 10 participants (non-randomized) receiving CBTI-CS via Telehealth.
Interventions
CBTI-CS is a multi-modal intervention designed to address both cognitive and behavioral factors that perpetuate insomnia. Cognitive factors are addressed via cognitive restructuring and psychoeducation. Behavioral factors are addressed by structured sleep restriction, stimulus control and sleep hygiene techniques. Cancer treatment late-effects affecting sleep are addressed as potential contributors to these cognitive and behavioral factors, and as symptoms that may benefit from referral for medical evaluation/management. Participants are instructed in these cognitive-behavioral strategies as a group, but using analysis of personal sleep-log data, symptom self-reports and targeted workbook exercises, they are helped to tailor the intervention to address their specific needs.
Education on health behaviors, sleep habits and environmental practices intended to promote good quality sleep. Recommendations target exercise and natural light exposure,use of stimulants and alcohol, daytime napping, timing of meals, creating a comfortable non-stimulating sleep space, and creating sleep rituals.
The CBTI-CS intervention, a multi-modal intervention designed to address both cognitive and behavioral factors that perpetuate insomnia, will be administered via live video. conferencing. Participants will have a single in-person training session and subsequent CBTI-CS group sessions will be conducted by live video conference.
Eligibility Criteria
You may qualify if:
- ≥ 18 years of age
- History of a cancer diagnosis
- No active cancer therapy (excluding chemoprevention) in the past year, and no cancer therapy planned in the next 6 months
- No surgery planned in the next 6 months
- Significant insomnia as evidenced by an Insomnia Severity Index score ≥12
- Able to read and write in English
- Willing to attend study group sessions
- Motivated and able to follow the demands of the CBTI-CS program, to keep sleep records, complete self-report symptom reports and make changes in their sleep schedule, including restricting their sleep.
You may not qualify if:
- Survivors who report ever being diagnosed with Bipolar Disorder will be excluded.
- Survivors who report ever being diagnosed with a Seizure Disorder or have experienced a seizure in the past 12 months will be excluded.
- Intention to adjust (decrease or increase) use of sedative, hypnotic, or over-the-counter medications that can affect sleep during the study period.
- Have diagnosed, untreated sleep apnea, or sleep apnea suspected by a physician but which has not been evaluated, or other sleep disorder
- Employment that involves irregular sleep patterns, such as shift-work or frequent long-distance travel that involves adjusting to different time zones, or employment in a position that could impact public safety (such as operating heavy machinery)
- Refusal to modify or reduce excessive alcohol use that is likely to interfere with an individual's sleep.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Dana-Farber Cancer Institutelead
- National Cancer Institute (NCI)collaborator
Study Sites (1)
Dana Farber Cancer Institute
Boston, Massachusetts, 02115, United States
Related Publications (1)
Zhou ES, Partridge AH, Recklitis CJ. A pilot trial of brief group cognitive-behavioral treatment for insomnia in an adult cancer survivorship program. Psychooncology. 2017 Jun;26(6):843-848. doi: 10.1002/pon.4096. Epub 2016 Feb 12.
PMID: 26872123BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christopher Recklitis, PhD, MPH
Dana-Farber Cancer Institute
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Christopher Recklitis, PhD, MPH
Study Record Dates
First Submitted
April 26, 2016
First Posted
April 29, 2016
Study Start
December 1, 2015
Primary Completion
May 14, 2018
Study Completion
May 14, 2018
Last Updated
December 11, 2018
Record last verified: 2018-12
Data Sharing
- IPD Sharing
- Will not share